Support Team Posted December 15, 2011 Posted December 15, 2011 An early stage II clinical trial from Calgary of a treatment called REOLYSIN® in combination with gemcitabine in patients with advanced pancreatic cancer has found that the drug appears to be active. Further trials are needed to find out if REOLYSIN® could have a role in the treatment of pancreatic cancer http://www.fiercebiotech.com/press-releases/oncolytics-biotech-inc-announces-phase-2-clinical-trial-reolysin-combinatio?utm_medium=nl&utm_source=internal
Recommended Posts